Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands by Xander, Nicolas S H, Fiets, W Edward, Uyl-de Groot, Carin A

Get full text

Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness by Leeneman, Brenda, Xander, Nicolas S.H., Fiets, W. Edward, de Jong, Wouter K., Uyl, Nathalie E.M., Wymenga, A.N. Machteld, Reyners, An K.L., Uyl-de Groot, Carin A.

Get full text

Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin... by Ham, Janneke C., Meerten, Esther, Fiets, W. Edward, Beerepoot, Laurens V., Jeurissen, Frank J. F., Slingerland, Marije, Jonker, Marianne A., Husson, Olga, Graaf, Winette T. A., Herpen, Carla M. L.

Get full text

796. P02.05 NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS STANDARD SURGERY FOR OESOPHAGEAL CANCER (SANO-TRIAL): A MULTICENTRE STEPPED-WEDGE CLUSTER-RANDOMISE... by Van Der Wilk, Berend, Eyck, Ben M, Wijnhoven, Bas PL, Lagarde, Sjoerd M, Rosman, Camiel, Noordman, Bo J, Valkema, Maria J, Bisseling, Tanya M, Coene, Peter-Paul LO, van Det, Marc J, Dekker, Jan-Willem T, van Dieren, Jolanda M, Doukas, Michail, van Esser, Stijn, Fiets, W Edward, Hartgrink, Henk H, Heisterkamp, Joos, Holster, I Lisanne, Klarenbeek, Bastiaan, van Klaveren, David, Kouw, Eva, Kouwenhoven, Ewout A, Luyer, Misha D, Mostert, Bianca, Nieuwenhuijzen, Grard AP, Oostenbrug, Liekele E, Pierie, Jean-Pierre, van Sandick, Johanna W, Sosef, Meindert N, Spaander, Manon CW, Valkema, Roelf, van der Zaag, Edwin S, Steyerberg, Ewout W, van Lanschot, J Jan B

Get full text

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients by Look, Maxime P., van Putten, Wim L. J., Duffy, Michael J., Harbeck, Nadia, Christensen, Ib Jarle, Thomssen, Christoph, Kates, Ronald, Spyratos, Frédérique, Fernö, Mårten, Eppenberger-Castori, Serenella, Sweep, C. G. J. Fred, Ulm, Kurt, Peyrat, Jean-Philippe, Martin, Pierre-Marie, Magdelenat, Henri, Brünner, Nils, Duggan, Catherine, Lisboa, Björn W., Bendahl, Pär-Ola, Quillien, Véronique, Daver, Alain, Ricolleau, Gabriel, Meijer-van Gelder, Marion E., Manders, Peggy, Fiets, W. Edward, Blankenstein, Marinus A., Broët, Philippe, Romain, Sylvie, Daxenbichler, Günter, Windbichler, Gudrun, Cufer, Tanja, Borstnar, Simona, Kueng, Willy, Beex, Louk V. A. M., Klijn, Jan G. M., O'Higgins, Niall, Eppenberger, Urs, Jänicke, Fritz, Schmitt, Manfred, Foekens, John A.

Get full text

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma by Kelderman, Sander, Heemskerk, Bianca, van Tinteren, Harm, van den Brom, Rob R. H., Hospers, Geke A. P., van den Eertwegh, Alfonsus J. M., Kapiteijn, Ellen W., de Groot, Jan Willem B., Soetekouw, Patricia, Jansen, Rob L., Fiets, Edward, Furness, Andrew J. S., Renn, Alexandra, Krzystanek, Marcin, Szallasi, Zoltan, Lorigan, Paul, Gore, Martin E., Schumacher, Ton N. M., Haanen, John B. A. G., Larkin, James M. G., Blank, Christian U.

Get full text